Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children-Reference-Cited by-同舟云学术

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children

Published:2023-07-04 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Sow Samba O.¹,Tapia Milagritos D.²,Haidara Fadima Cheick¹,Diallo Fatoumata¹,Traore Youssouf¹,Traoré Awa¹,Kodio Mamoudou¹,Borrow Ray³,Townsend-Payne Kelly³,Yuan Lin⁴,Yang Shuyuan⁴,Shi Lei⁴,Chen Jingjing⁴,Fang Guoliang⁴,Lin Jianxiang⁴,Hu Ruoyu⁴,Viviani Simonetta⁵,Huang Zhen⁴

Affiliation:

1. Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali

2. Department of Pediatrics, Division of Pediatric Infectious Diseases, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA

3. Vaccine Evaluation Unit, UK Health Security Agency, Public Health Laboratory, Manchester, UK

4. Walvax Biotechnology Co., Ltd., Kunming, Yunnan, China

5. Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy

Funder

Yuxi Walvax Biotechnology Co., Ltd

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2230829

Reference19 articles.

1. Identification of N. meningitidis serogroup and performing the SASG test 2021. 2021 [accessed 2021 Jan 27]. https://dermatologyadvisor.blogspot.com/2019/01/identification-of-n-meningitidis.html

2. Meningococcal a conjugate vaccine: updated guidance, February 2015;WHO;Wkly Epidemiol Rec,2015

3. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data

4. Epidemic meningitis control in countries of the African meningitis belt, 2017;WHO;Wkly Epidemiol Rec,2019

5. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges